Cagrilintide (25 mg) is a modern metabolic peptide with regulatory action, focused on supporting appetite control, eating behavior, and energy metabolism processes. Due to its effect on satiety regulation and metabolic balance mechanisms, the product is considered an element of weight management, appetite control, and comprehensive body weight reduction support programs.
Within weight management programs, Cagrilintide is used to support satiety regulation processes, reduce food-related impulses, and maintain the body’s metabolic balance. A gradual format of use allows individual adaptation characteristics and physiological response to be taken into account.
Indicative scheme for Cagrilintide:
| Period | Dose |
|---|---|
| Weeks 1–2 | 0.25–0.5 mg |
| Weeks 3–4 | 0.5–1 mg |
| Weeks 5–8 | Maintenance regimen |
| From week 9 | Individually according to the program |
The usage scheme is selected individually, taking into account the program goals, the characteristics of metabolic processes, and the overall functional state of the body. Before use, it is recommended to review the product information and consult a specialist.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.